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Western populations have a growing obesity epidemic due in part to
excessive nutrient intake from high-fat diets, which are increasingly
common. Overindulgence of nutrients is associated with a greater
incidence of metabolic dysfunction and a greater risk for obesity,
diabetes, hypertension, and other metabolic disorders that lower
quality of life. Research in humans and animal models has improved
our understanding of how excess circulating free fatty acids negatively
impact the ability of muscle and other tissues to regulate nutrient

uptake and utilization. It is generally accepted by the scientific
community that excess circulating fatty acids lead to insulin resistance,
but there is little clarity regarding the underlying mechanisms. In
the present review, we will outline the current understanding of the
characteristics associated with fatty acid mobilization and fatty acid
utilization within specific tissues. We will also discuss the potential
mechanistic role of hyperlipidemia on metabolic dysfunction associated
with type 2 diabetes.

INTRODUCTION

FFA in pathologies associated with obesity and type
2 diabetes. In this review, we describe the mechanisms by which disruption of fatty acid mobilization, skeletal muscle fatty acid utilization, and FFA
homeostasis result in metabolic pathologies and
disorders that reduce life span and lower quality of
life.

Epidemiological studies have identified metabolic
disorders and heart disease as health consequences
resulting from obesity in US and global populations.1 Greater accumulation of adipose tissue is
associated with physiological pathologies such as
hyperlipidemia, chronic inflammation, and insulin
resistance.2 A primary factor in these metabolic
pathologies is elevated circulating free fatty acids
(FFA), which is a common characteristic of obese
individuals and type 2 diabetics.2 High blood FFA
concentrations lead to reduced whole-body glucose
uptake and oxidation rates and also decrease skeletal muscle glycogen synthase.3 However, fatty acids
are also important components of complex lipids
that are necessary for structural and functional
integrity of cellular membranes. Due to the cytotoxic nature of FFA,4 lipolytic enzymes tightly regulate mobilization of fatty acids from triglycerides
stored within adipose tissue.4 Consequently,
enzymatic dysfunction contributes to pathologies
underlying the development of obesity and insulin
resistance, although metabolic factors, genetics,
and environment also play roles.5,6 Prolonged periods of elevated circulating FFA concentrations lead
to impaired hepatic lipoprotein production, poor
insulin responsiveness in skeletal muscle and liver,
and pancreatic β-cell dysfunction independent of
body composition.7 Recent studies have further
characterized FFA-induced pathologies by identifying receptors and signaling pathways involved in
the underlying mechanisms,8,9 as detailed in later
sections. This fundamental research has increased
our understanding of the role of high circulating

MECHANISM OF FATTY ACID
MOBILIZATION
In mammals, excess energy substrates are stored
as triglycerides in adipose tissue and can be
mobilized to maintain a balance of stored and
circulating lipid concentrations.5 Storage, synthesis, and utilization of adipose triglycerides is
regulated by hormonal and paracrine factors in
response to changing blood FFA concentrations.5
Circulating FFA concentrations are determined
by the rate at which they are mobilized and enter
circulation combined with the rate at which they
are cleared and deposited into adipose tissue, as
illustrated in Figure 1. Fatty acid mobilization
typically increases when the body enters into a
hypoglycemic state due to fasting or an increase
in adrenergic stimulation.10 Catecholamines from
the sympathetic nervous system or the adrenal
medulla are the primary stimulants of fatty acid
mobilization, especially in response to stress
conditions.10 Catecholamines directly affect fat
cells via G protein-coupled receptors. Binding of β
or α2 adrenergic receptors on adipocytes activates
the signaling cascades illustrated in Figure 2 that
stimulate adenylate cyclase-mediated increases
in cyclic adenosine 3, 5-monophosphate (cAMP)
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Excessive fatty acid accumulation can be cytotoxic
and therefore uptake and storage of fatty acids is
tightly regulated.7,12 Once fatty acids are inside
the cell, cytosolic fatty acid binding proteins and
transport proteins chaperone fatty acids to the
mitochondria to be metabolized for energy via
β-oxidation.9,14 Dysfunctional mobilization often
results in greater postprandial FFA plasma concentrations, which is a hallmark characteristic of individuals with type 2 diabetes.

FATTY ACID ACCUMULATION IN
SKELETAL MUSCLE TISSUE

Figure 1 Concentrations of free fatty acids (FFA) in the bloodstream are
determined by the combined rates at which they are mobilized /
secreted into circulation and cleared from circulation.

Figure 2 
Catecholamines stimulate fatty acid mobilization from adipocytes. Binding of β or α2 adrenergic G protein-coupled receptors
activates second messenger signal cascades that include adenylate
cyclase-mediated increases in cyclic adenosine 3, 5-monophosphate (cAMP), activated cAMP-dependent protein kinase A (PKA),
phosphorylated hormone sensitive lipase (HSL), and ultimately
catabolized triglycerides. Adipose triglyceride lipase (ATGL) and
HSL facilitate hydrolysis of triglycerides, and Perilipin A mediates
FFA secretion. FFA travel in circulation bound to carrier proteins.
which in turn activates cAMP-dependent protein
kinase A (PKA).5,7,11 Active PKA phosphorylates
hormone sensitive lipase (HSL) that then catabolizes triglycerides stored within the adipocyte.7,12 In
the cytosol, adipose triglyceride lipase (ATGL) and
HSL adhere to lipid droplets to facilitate hydrolysis
of triglycerides.13 Perilipin A, a structural protein
located on the surface of lipid droplets, then mediates the release of fatty acids into circulation.5,7,12
2
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The mechanism by which fatty acids impair insulin-stimulated glucose oxidation in skeletal muscle
has been described.3,15,16 Furthermore, studies
have elucidated that the triglyceride content of
muscle has a negative relationship with wholebody insulin sensitivity. Pan et al.17 performed
hyperinsulinemic-euglycemic clamp studies on
non-diabetic, overweight adult males to determine
whole-body insulin sensitivity and then analyzed
vastus lateralis biopsies for triglyceride content.
Their results showed a negative correlation between
the two. In order to further explain this relationship, in vivo studies18,19 have investigated how
the source of triglycerides affects skeletal muscle
insulin resistance by isolating extramyocellular
and intramyocellular lipid fractions.18-21 Krssak
et al.22 characterized the negative relationship of
intramyocellular lipid fractions on whole body
glucose uptake by demonstrating that intramyocellular stores are primarily responsible for increasing
skeletal muscle insulin resistance. These discoveries
helped subsequent investigators clarify the role
of other cellular components by identifying and
isolating receptors and intracellular intermediates
associated with FFA accumulation and insulin
resistance, with initial focus on glucose oxidation.
Indeed, early research has shown that FFA concentrations and glucose metabolism impact each
other,15,23,24 and more recent studies have begun to
identify the intracellular axes and gene transcripts
involved.8,9,14
FFA are transported from blood into skeletal
muscle cells using fatty acid binding proteins
(FABP) and fatty acid transport proteins (FATP).
Collectively, there are a number of members of
the FATP family that include FATP1, FATP4, and
FATP6.14 In addition to FFA transport, these FATP
may have acyl-CoA synthetase enzymatic activity,
which activates FFA for metabolism.9 FATP1 is
the most prevalent transport protein expressed
by skeletal muscle.14 It has a central role in fatty
acid transport in T-tubules and it increases FFA
www.diabesity.ejournals.ca
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oxidation in response to insulin stimulation.14
However, when FFA uptake occurs at a faster rate
than FFA oxidation, it causes an accumulation of
lipid intermediates that results in lipotoxic stress.25
Lipotoxicity results from excess intramyocellular
buildup of triacylglycerol, diacylglycerol, longchain acyl CoA, and ceramides. The mechanism
is not fully understood, but elevated lipid intermediates such as ceramides and diacylglycerol
appear to impair insulin signaling in skeletal
muscle.8 Ceramides are generated through a de
novo pathway via condensation of palmitoyl CoA
and serine.8 Ceramides are elevated in diabetic
patients and inhibit a number of protein kinases,
which are otherwise stimulated by insulin. They
also likely activate the atypical protein kinase C
isoforms within insulin-responsive tissues.13 This
represents one potential mechanistic outcome
whereby dysfunctional FFA mobilization and the
resulting accumulation contribute to the development of skeletal muscle insulin resistance. In
contrast, research has demonstrated that elevated
triacylglycerol content in skeletal muscle is
common among high-endurance athletes despite
adequate hydrolysis of FFA.13 Individuals who
undergo endurance training also have elevated
ATGL expression in skeletal muscle cells, which
is associated with increased oxidative capacity.13
Due to the increased energy demand of these
athletes, increased lipolysis presumably helps fuel
the requirements for their bodies’ work output.
Therefore, increased levels of circulating triacylglycerol in endurance athletes are understandable;
however, further research is needed to identify
what mechanisms are involved in maintaining
insulin sensitivity in these individuals.

HEPATIC LIPID METABOLISM
The liver is a major regulator of lipid flux and plays
a crucial role in maintaining FFA blood plasma
concentrations.26 Hepatic FFA accumulation can
occur as a consequence of decreased FFA oxidation,
excessive FFA liberation from lipolyzed adipose
triglycerides, inadequate triacylglycerol excretion,
or hepatic de novo lipogenesis.26 Greater hepatic fat
content from any of these mechanisms can contribute to the development of insulin resistance and
type 2 diabetes.27 Most FFA taken up from circulation by the liver had entered the bloodstream after
being mobilized from adipose tissue.26 The nuclear
receptor peroxisome proliferator-activated receptor
alpha (PPARα) senses the hepatic influx of circulating FFA and upregulates gene expression of fatty
acid oxidative systems.28 The lab of JK Reddy28-31
identified this regulation mechanism by knocking out the genes for PPARα and fatty acyl-CoA
www.diabesity.ejournals.ca

oxidase (ACOX) in mice. These mice were consequently unable to upregulate genes associated with
fatty acid oxidation systems, and the subsequent
increase in triglyceride synthesis contributed to the
development of liver steatosis.28-31 Mitochondrial
β-oxidation is a complex process that is regulated
in part by enzymatic activity of carnitine palmitoyltransferase 1 and by concentrations of carnitine
and malonyl-CoA. For β-oxidation to occur, intracellular FFA must first be activated into esters by
acyl-CoA synthetase in order to enter the mitochondrial β-oxidation spiral.31 Downregulation of
ACOX in the liver damages this transport system
and thus decreases FFA oxidation within the cell.31
Regardless of the tissue, proper regulation and
balance of FFA mobilization and oxidation is critical to maintain.

FATTY ACID-INDUCED PANCREATIC
Β-CELL DYSFUNCTION
Ex vivo studies have shown that prolonged exposure of rat pancreatic islets to elevated FFA concentrations decreases glucose-stimulated insulin
secretion.32,33 The impact of elevated circulating
FFA concentrations on human β-cell function is
less clear, as insulin secretion was increased after
6-hour FFA infusion but decreased after 24 hours
in non-obese healthy individuals.34 When individuals were made chronically hyperglycemic,
however, insulin secretion was increased by FFA
infusion for 48 hours.35 Nevertheless, lipotoxicity is
a potential source of β-cell injury in patients with
type 2 diabetes.36 Deleterious effects on β-cells from
prolonged exposure to high FFA concentrations are
indicated by studies showing inhibition of insulin
mRNA expression and increased ceramide production that led to nitric oxide-dependent cell death.36
Increased accumulation of islet amyloid after FFA
exposure causes islet amyloidosis and inflammation.37 Amyloid deposition is associated with less
islet volume due to a reduction in β-cell mass.38
It is important to note that some individual fatty
acids such as palmitate can actually suppress β-cell
dysfunction and demise,39,40 since these saturated
fatty acids act as inhibitors of pyruvate carboxylase
activity.41 It is clear that research has only begun
to uncover how FFA concentrations impact β-cell
function independent from fat mass. However, we
have a better understanding of how these energy
intermediates contribute to impaired insulin secretion and function in type 2 diabetes.

CONCLUSION
Dysregulation of fatty acid storage, mobilization,
and metabolism is implicit in a number of metabolic
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diseases. It is becoming clear that the loss of free
fatty acid homeostasis is at least partially independent of obesity, which furthers our understanding
of the fatty acid cycle and its role in metabolic
disease. However further research is warranted to
elucidate the mechanistic details of these changes
in fatty acid flux in order to address the growing
global metabolic syndrome epidemic. Exploration
of transcriptional modifications, understanding
and isolating mechanisms underlying the “athlete
phenomenon,” and developing the basis for FFA
therapies are fundamental steps in providing a
better understanding of the interactive role that
FFA flux plays in metabolic disease and improving
outcomes in these individuals.
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